The high occurrence of atherosclerotic cardiovascular disease (ASCVD) events is still a
major public health issue. Although a major determinant of ASCVD event reduction is the …

Aims The aim of this study was to evaluate the low-density lipoprotein cholesterol lowering
efficacy and safety of a bempedoic acid 180 mg and ezetimibe 10 mg fixed-dose …

Background and aims One of the objectives of the ESC-EORP EUROASPIRE V survey is to
determine how well European guidelines on the management of dyslipidaemias are …

Introduction: Tolerability problems in treating hypercholesterolemic patients undergoing
statin treatment are of growing concern to physicians and patients, thus underlining the need …

Background and aims Many patients with hypercholesterolemia fail to achieve sufficient low-
density lipoprotein cholesterol (LDL-C) lowering despite use of guideline-recommended …

Background and aims Central and Eastern Europe (CEE) is a largely understudied region,
despite having the highest cardiovascular disease mortality in Europe. This analysis aimed …

Background After percutaneous coronary interventions (PCIs), patients remain at high risk of
developing late cardiovascular events. Although controlling low-density lipoprotein …

Background: This paper describes the health and economic burden of cardiovascular
diseases (CVD) in Mexico and other mega-countries through a review of literature and …

Dyslipidemia, specifically abnormal levels of low-density lipoprotein cholesterol (LDL-C), is
an important risk factor of cardiovascular disease. Evidence showing the promising abilities …

Despite steady improvements in cardiovascular disease (CVD) prevention, a scarce
proportion of patients achieve the recommended LDL-C goals, even under high-intensity …